...

Our Open Access journals

Cover of Disease Models & Mechanisms, volume 17 issue 9, showing an axolotl Cover of Biology Open, volume 13 issue 11, showing a glutaraldehyde-enhanced autofluorescence of a rotifer

We publish two fully Open Access journals: Disease Models & Mechanisms and Biology Open. These journals are 100% Open Access, making your research easily and immediately available to everyone to read and share. Our fully Open Access journals are included in the majority of our Read & Publish agreements.

Both of these Open Access journals offer article processing charge waivers for corresponding authors based in low-income and lower-middle-income economies (as classified by the World Bank), as well as full waivers as part of our agreement with Electronic Information for Libraries (EIFL) . More information about Open Access fee waiver policies can be found on the Open Access pages of Disease Models & Mechanisms and Biology Open.

 

Our transformative journals

Cover of Development, volume 151 issue 16, showing a superimposition of three stages of embryonic mouse lungs Cover of Journal of Cell Science, volume 137, issue 16, showing Scanning electron micrograph (SEM) of a human macrophage Cover of Journal of Experimental Biology, volume 227 issue 23, showing an Adélie penguin leaping from the water

As hybrid journals, Development, Journal of Cell Science and Journal of Experimental Biology already offered Open Access publishing options. As transformative journals, we are working towards a greater percentage of Open Access content year on year. We promise to be transparent about all publishing options that we offer and about our pricing structure. We are actively working together with institutes through our Read & Publish initiative to offer authors worldwide a choice of publishing routes.

We have seen considerable growth in the percentage of Open Access content in all three of our transformative journals over the past few years, driven by our Read & Publish initiative.

Graph showing OA as a percentage of Research Articles growing year on year from 2020 to 2024 for Development, Journal of Cell Science and Journal of Experimental Biology

We look forward to continued Open Access growth, offering authors easy and compliant routes to publish with us.

What does this mean for authors?

Authors have a number of routes to publication in DevelopmentJournal of Cell Science and Journal of Experimental Biology.

Free publication (not Open Access)

With this option, the author pays nothing at all. The article is available to our subscribers for 12 months and is then freely available to everyone after this time.

This option might appeal to authors whose funders and institutions do not mandate Open Access and authors who do not want to choose Open Access or pay an Open Access fee. This option could be important given the financial challenges within the university sector.

Open Access (author pays)

The author will pay an article processing charge (APC) to publish their article Open Access. Articles will be published under a CCBY licence and will be available to everyone immediately upon publication.

This option will appeal to authors whose funders or institutions mandate Open Access or to authors who prefer to publish Open Access.

Free Open Access through Read & Publish agreements

The third option is for authors whose institutions have taken up one of our Read & Publish agreements. These cost-neutral agreements, agreed with librarians, provide unlimited access to all of our content and allow corresponding authors from that institution unlimited APC-free Open Access publication for research articles. These agreements therefore support institutions and authors working to meet funding requirements and to make Open Access the default publishing choice. New Read & Publish agreements are added regularly and we have had overwhelmingly positive feedback from authors who have used this route.

Rights Retention Strategy

For authors who may need to follow the Rights Retention Strategy to comply with funder/institute mandates, we do allow this route to self-archiving of the Author Accepted Manuscript (in an institutional or subject repository immediately under a CC BY license) in cases where none of our standard routes (outlined above) comply with the relevant mandate.

Read & Publish agreements

Learn more about our Read & Publish initiative, which supports our Open Access growth.

Fair pricing policy

We review our subscription pricing policy annually to ensure that our customers do not pay twice for access to this content via article processing charges (APCs) and subscription fees – also known as “double dipping”.

Our journals

Find out more about Open Access publishing in our five journals

Democratising access to research – our long-standing commitment to Open Access publishing

Updated 20 August 2024

The scholarly communication landscape has changed profoundly over the past two decades, with a profusion of new publishing and subscription models from commercial and not-for-profit publishers. The increasing importance of Open Access (OA) – making research immediately and freely available to all – has presented challenges as well as opportunities for libraries, funding organisations, publishers and researchers alike.


Visit our journal websites

Development Journal of Cell Science The Journal of Experimental Biology Disease Models & Mechanisms Biology Open

© 2025 The Company of Biologists Ltd | Registered Charity 277992
Registered in England and Wales | Company Limited by Guarantee No 514735
Registered office: Bidder Building, Station Road, Histon, Cambridge CB24 9LF, UK